FDA clears Axilum Robotics’ system for TMS positioning

(Image from Axilum Robotics)

Strasbourg, France-based Axilum Robotics said today that it has received 510(k) clearance from FDA for its TMS-Cobot TS MV, indicated for the spatial positioning and orientation of the treatment coil of the MagVenture TMS Therapy system.

Transcranial magnetic stimulation (TMS) is a non-invasive neurostimulation technique. Its approved and potential applications range from neuroscience research to the treatment of drug-resistant neurological or psychiatric diseases.

Get the full story on our sister site, Medical Design & Outsourcing.

 

The post FDA clears Axilum Robotics’ system for TMS positioning appeared first on MassDevice.

from MassDevice https://ift.tt/2NroArN